Merck (MRK) Current Assets (2009 - 2026)

Merck (MRK) has 18 years of Current Assets data on file, last reported at $35.0 billion in Q1 2026.

• Current Assets for Q1 2026 came in at $35.0 billion, down 1.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.0 billion (down 1.37% YoY), and the FY2025 annual result was $43.5 billion, up 12.21% from the prior year.
• Current Assets fell to $35.0 billion in Q1 2026 per MRK's latest filing, from $43.5 billion in the prior quarter.
• Over five years, Current Assets peaked at $47.6 billion in Q3 2025 and troughed at $30.0 billion in Q2 2023.
• A 5-year average of $35.7 billion and a median of $35.0 billion in 2026 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2024: Current Assets slipped 9.95% in 2023, then grew 27.45% in 2024.
• A 5-year view of Current Assets shows it stood at $35.7 billion in 2022, then slipped by 9.95% to $32.2 billion in 2023, then increased by 20.56% to $38.8 billion in 2024, then climbed by 12.21% to $43.5 billion in 2025, then retreated by 19.54% to $35.0 billion in 2026.
• Business Quant data shows MRK's Current Assets at $35.0 billion in Q1 2026, $43.5 billion in Q4 2025, and $47.6 billion in Q3 2025.